Back to top

Curis (CRIS) Launches Phase 2 CLL Study and Plans Reverse Stock Split

Curis (CRIS) Launches Phase 2 CLL Study and Plans Reverse Stock Split

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Curis, Inc. (CRIS)